 |
Monica Heger tracks trends in next-generation sequencing for research and clinical applications for GenomeWeb's In Sequence and Clinical Sequencing News. E-mail Monica Heger or follow her GenomeWeb Twitter accounts at @InSequence and @ClinSeqNews. |
NIPT Developers Surprised by Illumina's Verinata Acquisition, But Say it Validates the Field
January 16, 2013
NIPT Developers Surprised by Illumina's Verinata Acquisition, But Say it Validates the Field
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Prenatal Sequencing Becoming Standard of Care in Increasingly Litigious Market
January 16, 2013 / Clinical Sequencing News - MaterniT21 Doubles Sequenom's Revenues; Firm Inks Deal with Blue Cross Blue Shield Association
May 15, 2013 / Clinical Sequencing News - NIPT Developers Consider Sub-Chromosomal Alterations
May 1, 2013 / Clinical Sequencing News - USPTO Grants Ariosa Request to Review Key Sequenom Patent
April 3, 2013 / Clinical Sequencing News - Ariosa, LabCorp File Motion to Dismiss Patent Infringement Suit Filed by Verinata
January 23, 2013 / Clinical Sequencing News